Current Deferred Revenue (Quarterly) Chart

View Current Deferred Revenue (Quarterly) for MRNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Quarterly) Benchmarks

View Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. --
Merck & Co., Inc. --
Pfizer Inc. Upgrade
Bristol Myers Squibb Co. --
Novavax, Inc. Upgrade